Fully Automated Pipeline for the Detection and Segmentation of Non-Small Cell Lung Cancer (NSCLC) on CT Images

NCT ID: NCT04164186

Last Updated: 2020-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1043 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-10

Study Completion Date

2020-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Accurate segmentation of lung tumor is essential for treatment planning, as well as for monitoring response to therapy. It is well-known that segmentation of the lung tumour by different radiologists gives different results (inter-observer variance). Moreover, if the same radiologist is asked to repeat the segmentation after several weeks, these two segmentations are not identical (intra-observer variance). In this study we aim to develop an automated pipeline that can produce swift, accurate and reproducible lung tumor segmentations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, we aim to develop and test an automated deep learning detection and segmentation software for non-small cell lung cancer (NSCLC) that can automatically detect and segment tumors on CT scans and thus reduce the human variation. We will assess the level of agreement between a group of radiologists, performing manual versus semi-automatic tumour segmentation. To do so, we will provide radiologists with two sets of CT scans. The first set will be segmented manually; the second one will be segmented using the automated software program.

Subsequently, we will use the inter- and intra-observer variance from the clinical study in a simulation or modeling study. We also compare the time needed and the consistency in segmentations by the software to medical doctors performance.

Reliability and Agreement study:

Primary tumours of 25 lung cancer patients will be delineated by 6 segmentation experts.

1. Assess agreement between automatic segmentation and radiologists' segmentation The primary tumours of 25 patients will be manually segmented by the radiologists and automatically by the the tool. The time needed to perform this task and the reproducibility of the segmentation will be recorded. The degree of overlap between the ROs and the automatic contour will be assessed pairwise using the Dice coefficient.
2. Delination of tumours by the experts, assisted by the software tool For another 25 patients, the experts will be provided with an automatic delineation, performed by the tool. They have the possibility to adjust and validate it. The time needed will be recorded. The difference between the mean overlap fraction in the first situation (manual delineation of experts) and the second situation (delineation of experts+ software tool) will be assessed, using a multi-observer Dice coefficient.
3. Assessment of intra-observer variance The experts will repeat the segmentation of the lung tumours after 2 weeks. They will repeat the manual segmentation (n=25) and the semi-automatic segmentation (n=25). This will make it possible to assess the intra-observer variance in both situations.
4. Qualitative assessment of the experts' preferences using an in-house developed visualization toolbox.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Detection Segmentation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Automatic detection and segmentation of NSCLC tumors

an automated deep learning detection and segmentation software for non-small cell lung cancer (NSCLC) that can automatically detect and segment tumors on CT scans and thus reduce the human variation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Availability of CT scans
* Availability of definite diagnosis

Exclusion Criteria

* Lack of segmentations
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Liege

OTHER

Sponsor Role collaborator

University Hospital RWTH Aachen University, Aachen, Germany.

UNKNOWN

Sponsor Role collaborator

Affiliated Zhongshan Hospital of Dalian University, 6 Jiefang street, Dalian 116001, China

UNKNOWN

Sponsor Role collaborator

University of California, San Francisco

OTHER

Sponsor Role collaborator

Maastricht University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maastricht University

Maastricht, Limburg, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.

Document Type: Individual Participant Data Set

View Document

Document Type: Individual Participant Data Set

View Document

Document Type: Individual Participant Data Set

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ALSP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

99mTc-H7ND SPECT/CT Imaging in NSCLC
NCT05999214 RECRUITING NA